Triamcinolone Acetonide and 5-Fluorouracil Intralesional Combination Injection in Keloid Treatment

Jono Hadi Agusni, Eva Krishna Sutedja, Franky Chandra

Abstract


Objective: To evaluate the effectiveness of steroid and 5-fluorouracil (5-FU) injection combination for keloid management.

Methods: A 22-year-old female patient was presented with recurrent skin lesions. The skin lesions first appeared 10 years prior to consultation, had been surgically excised, and were given triamcinolone acetonide injection. However, no improvement was observed. A decision was made to use and evaluate treatment using an intralesional 4 mg (0.1 ml of 40 mg/ml) triamcinolone acetonide and 45 mg (0.9 ml of 50 mg/ml ) 5-FU injection combination for 5 weeks.

Results: Clinical improvements were observed in the third week as the lesions softened and pruritic sensation dinimished. At the end of the fifth week, improvements in the form of keloid lesion flattening and size reduction were observed.

Conclusions: Intralesional injection using a combination of triamcinolone acetonide and 5-fluorouracil is effective for keloid lesion treatment.

Keywords: 5-fluorouracil, intralesional injection, keloid, triamcinolone acetonide

 

DOI: 10.15850/ijihs.v5n1.959


Keywords


5-fluorouracil, intralesional injection, keloid, triamcinolone acetonide

Full Text:

PDF

References


Pratchyapruit W, Vashrangsi N. A new therapeutic modality intralesional 5-fluorouracil in the treatment of keloids and hypertrophic scar. Inst Dermatol Ass. 2012;13(9):157–63.

Kelly AP. Update on the management of keloids. Semin Cutan Med Surg. 2009;28(2):71–6.

Sharma S, Bassi R, Gupta A. Treatment of small keloids with intralesional 5-fluorouracil alone vs intralesional triamcinolone acetonide with 5-fluorouracil. J Pak Assoc Dermatol. 2012;22(1):35–40.

Guimarães CO, Parada MB, Bagatin E. Keloid treatment:comparative intralesional injections of 5-fluorouracil, corticosteroid and 5-fluorouracil combined with corticosteroid. Surg Cosmet Dermatol. 2011;3(1):60–2.

Wolfram D, Tzankov A, Pulzi P, Piza-Katzer H. Hypertrophic scars and keloids-A review of their pathophysiology, risk factors, and therapeutic management. Dermatol Surg. 2009;35(2):171–81.

Khan MA, Bashir MM, Khan FA. Intralesional triamcinolone alone and in combination with 5-fluorouracil for the treatment of keloid and hypertrophic scars. J Pak Med Assoc. 2014;64(9):1003–7.

Gauglitz GG, Korting HC, Pavicic T, Ruzicka T, Jeschke MG. Hypertrophic scarring and keloids: Pathomechanisms and current and emerging treatment strategies. Mol Med. 2011;17(1):113–25.

Gauglitz GG. Management of keloids and hypertrophic scars:current and emerging options. Clin Cosmet Investig Dermatol. 2013;6(1):103-14.

Chike-Obi CJ, Cole PD, Brissett AE. Keloids: Pathogenesis, clinical features, and management. Semin Plast Surg. 2009;23(3):178–84.

Vivas AC, Tang JC, Maderal AD, Viera MH. Hypertrophic scars and keloids, part 1:conventional treatments. Cosmet Dermatol. 2012;25(3):309–16.

Edriss AS, Smrcka V. Therapy of keloid and hypertrophic scars:a review. Eur J Plast Surg. 2011;34(5):425–36.

Dong X, Mao S, Wen H. Upregulation of proinfammatory genes in skin lesions may be the cause of keloid formation. Biomed Rep. 2013;1(6):833–6.

Gupta S, Sharma VK. Standard guidelines of care: keloids and hypertrophic scars. Indian J Dermatol Venereol Leprol. 2011;77(1):94-100.

Darougheh A, Asilian A, Shariati F. Intralesional triamcinolone alone or in combination with 5-fluorouracil for the treatment of keloid and hypertrophic scars. Clin Exp Dermatol. 2009;34(1):219–23.

Kranendonk S, Obagi S. An algorithmic approach to hypertrophic scars and keloids:maximizing nonsurgical options. J Cosmet Dermatol. 2011;24(1):28–39.

Indrayati H, Agusni JH, Soedarwoto A, Kartamihardja AHS. Comparison of the effectiveness of phosphorus 32 application and 10 mg/cc triamcinolone acetonide intralesional injection on keloid. IJIHS. 2016;4(1):26–31.


Refbacks

  • There are currently no refbacks.




This journal indexed by:

             

  

Creative Commons License
IJIHS is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License



View My Stats